Related Experiment Videos
[Clinical probes using tumor necrosis factor in treatment of neoplastic diseases]
A Szczepanik1, J Tabor, M Siedlar
1Zakładu Immunologii Klinicznej, i Mikrobiologii Polsko-Amerykańskiego, Instytutu Pediatrii Akademii Medycznej, Krakowie.
Abstract:
Tumor necrosis factor-TNF is a cytokine that is predominantly produced by the activated macrophages. It was shown that TNF has the antineoplastic activity in vitro or in tumor xenografts on the animals in vivo. Clinical trials phase I and II carried out in many centers assessed toxic effects of TNF administration, as well as its pharmacokinetic and therapeutic effect. The following paper is a survey of the results of clinical trials which could be useful for the assessment of TNF role in oncological immunotherapy.
Insights
Tumor necrosis factor (TNF), a cytokine from macrophages, exhibits anti-cancer properties in lab and animal studies. Clinical trials are evaluating its safety and effectiveness for cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Cytokine Biology
Context:
- Tumor necrosis factor (TNF) is a key cytokine produced by activated macrophages.
- Preclinical studies demonstrate TNF's antineoplastic activity in vitro and in vivo tumor models.
- TNF is being investigated for its potential in cancer treatment.
Purpose:
- To survey and assess the results of clinical trials involving TNF administration.
- To evaluate the toxic effects, pharmacokinetics, and therapeutic efficacy of TNF.
- To determine the role of TNF in oncological immunotherapy.
Summary:
- This paper reviews clinical trial data (Phase I and II) on Tumor Necrosis Factor (TNF).
- The review focuses on assessing TNF's toxic effects, pharmacokinetics, and therapeutic outcomes.
- Findings aim to inform the evaluation of TNF's contribution to cancer immunotherapy.
Impact:
- Provides a comprehensive overview of clinical findings for TNF in cancer treatment.
- Informs future research and clinical applications of TNF for oncological immunotherapy.
- Contributes to understanding the therapeutic potential of cytokines in cancer care.